Physiologic insulin delivery with insulin feedback: A control systems perspective

IFAC Proceedings Volumes (IFAC-PapersOnline)

Volumn 7, Issue PART 1, 2009, Pages 31-36

  Palerm, Cesar C ^a  

^a MEDTRONIC INC   (United States)

Author keywords

Biomedical control system; Blood glucose control; Cascade control; Diabetes; Medical systems; Model approximation; PID control

Indexed keywords

BIOLOGICAL SYSTEMS; CLINICAL RESEARCH; CYTOLOGY; DISEASE CONTROL; FEEDBACK; GLUCOSE; INSULIN; MAN MACHINE SYSTEMS; MEDICAL PROBLEMS; PATIENT TREATMENT; PHYSIOLOGY; THREE TERM CONTROL SYSTEMS;

BIOMEDICAL CONTROL; BLOOD GLUCOSE; CASCADE CONTROL; MEDICAL SYSTEMS; MODEL APPROXIMATIONS;

CASCADE CONTROL SYSTEMS;

EID: 74249099752     PISSN: 14746670     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.3182/20090812-3-DK-2006.0077     Document Type: Conference Paper

References (41)

1. American College of Endocrinology (2002). American College of Endocrinology consensus statement on guidelines for glycemic control. Endocr Pract, 8 (Suppl 1), 5-11.
2. American Diabetes Association (2009). Standards of medical care in diabetes-2009. Diabetes Care, 32(Suppl 1), S13-S61. doi:10.2337/dc09-S013.
3. Argoud, G.M., Schade, D.S., and Eaton, R.P. (1987). Insulin suppresses its own secretion in vivo. Diabetes, 36(8), 959-962. (Pubitemid 17136810)
4. Bequette, B.W. (2005). A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther, 7(1), 28-47. doi: 10.1089/dia.2005.7.28. (Pubitemid 40354574)
5. Coetzee, J.F., Glen, J.B., Wium, C.A., and Boshoff, L. (1995). Pharmacokinetic model selection for target controlled infusions of propofol. Anesthesiology, 82, 1328-1345.
6. DeFronzo, R.A., Binder, C., Wahren, J., Felig, P., Ferrannini, E., and Faber, O.K. (1981). Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia. Acta Endocrinol (Copenh), 98(1), 81-86. (Pubitemid 11023925)
7. Diabetes Control and Complications Trial Research Group (1997). Hypoglycemia in the diabetes control and complications trial. Diabetes, 46(2), 271-286.
8. Diabetes Control and Complications Trials Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 329(14), 977-986.
9. Draznin, B., Goodman, M., Leitner, J.W., and Sussman, K.E. (1986). Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets. Endocrinology, 118(3), 1054-1058. (Pubitemid 16080137)
10. El-Khatib, F.H.A. (2005). System identification and adaptive closed-loop glucose control in a type 1 diabetic swine model. Ph.D. thesis, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
11. Gillis, R., Palerm, C.C., Zisser, H., Jovanovič, L., Seborg, D.E., and Doyle III, F.J. (2007). Glucose estimation and prediction through meal responses using ambulatory subject data for advisory mode model predictive control. J Diabetes Sci Technol, 1(6), 825-833.
12. Heptulla, R.A., Rodriguez, L.M., Bomgaars, L., and Haymond, M.W. (2005). The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes, 54(4), 1100-1107. (Pubitemid 40446324)
13. Hovorka, R. (2006). Continuous glucose monitoring and closed-loop systems. Diabet Med, 23(1), 1-12. doi: 10.1111/j.1464-5491.2005.01672.x.
14. Hovorka, R., Chassin, L.J., Wilinska, M.E., Canonico, V., Akwi, J.A., Federici, M.O., Massi-Benedetti, M., Hutzli, I., Zaugg, C., Kaufmann, H., Both, M., Vering, T., Schaller, H.C., Schaupp, L., Bodenlenz, M., and Pieber, T.R. (2004). Closing the loop: the adicol experience. Diabetes Technol Ther, 6(3), 307-18. doi:10.1089/152091504774197990. (Pubitemid 38821615)
15. Hunt, J.N. and Stubbs, D.F. (1975). The volume and energy content of meals as determinants of gastric emptying. J Physiol, 245(1), 209-225.
16. Jastremski, M., Jastremski, C., Shepherd, M., Friedman, V., Porembka, D., Smith, R., Gonzales, E., Swedlow, D., Belzberg, H., Crass, R., Jannett, T., Richards III, E., Thys, D., and Woods, D. (1995). A model for technology assessment as applied to closed loop infusion systems. Crit Care Med, 23(10), 1745-1755.
17. Marrero, D.G., Crean, J., Zhang, B., Kellmeyer, T., Gloster,M., Herrmann, K., Rubin, R., Fineberg, N., and Kolterman, O. (2007). Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes. Diabetes Care, 30(2), 210-216. doi:10.2337/dc06-1026. (Pubitemid 46198321)
18. Monnier, L. and Colette, C. (2008). Glycemic variability: should we and can we prevent it? Diabetes Care, 31 Suppl 2, S150-S154. doi:10.2337/dc08-s241.
19. Mudaliar, S.R., Lindberg, F.A., Joyce, M., Beerdsen, P., Strange, P., Lin, A., and Henry, R.R. (1999). Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care, 22(9), 1501-1506. (Pubitemid 29418246)
20. Packer, J.S. (1990). Patient care using closed-loop computer control. Comput Control Eng J, 1(1), 23-28.
21. Palerm, C.C. (2003). Drug infusion control: an extended direct model reference adaptive control strategy. Ph.D. thesis, Rensselaer Polytechnic Institute, Troy, NY, USA.
22. Palerm, C.C., Kurtz, N., Paz, S., Keenan, D.B., Steil, G.M., and Kandeel, F.R. (2008a). Closed-loop insulin delivery utilizing insulin feedback: preliminary clinical results. In Eighth Annual Diabetes TechnologyMeeting, S44. Bethesda, MD, USA.
23. Palerm, C.C., Zisser, H., Bevier,W.C., Jovanovič, L., and Doyle III, F.J. (2007). Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric. Diabetes Care, 30(5), 1131-1136. doi:10.2337/dc06-2115. (Pubitemid 46684637)
24. Palerm, C.C., Zisser, H., Jovanovič, L., and Doyle III, F.J. (2008b). A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes. J Process Contr, 18(3-4), 258-265. doi:10.1016/j.jprocont. 2007.07.010. (Pubitemid 351380458)
25. Panteleon, A.E., Loutseiko, M., Steil, G.M., and Rebrin, K. (2006). Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system. Diabetes, 55(7), 1995-2000. doi:10.2337/db05-1346. (Pubitemid 44509972)
26. Parker, R.S. and Doyle, III, F.J. (2001). Control-relevant modeling in drug delivery. Adv Drug Deliv Rev, 48, 211-228. doi:10.1016/S0169-409X(01)00114- 4. (Pubitemid 32434404)
27. Quesada, I., Tuduri, E., Ripoll, C., and Nadal, A. (2008). Physiology of the pancreatic ?-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol, 199(1), 5-19. doi:10.1677/JOE-08-0290.
28. Rodriguez, L.M., Mason, K.J., Haymond, M.W., and Heptulla, R.A. (2007). The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes. Pediatr Res, 62(6), 746-749. doi:10.1203/PDR.0b013e318159af8c. (Pubitemid 350158818)
29. Scherbaum, W.A. (1998). The role of amylin in the physiology of glycemic control. Exp Clin Endocrinol Diabetes, 106(2), 97-102. (Pubitemid 28209733)
30. Singh-Franco, D., Robles, G., and Gazze, D. (2007). Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus. Clin Ther, 29(4), 535-562. doi: 10.1016/j.clinthera.2007.04.005. (Pubitemid 47016638)
31. Steil, G.M., Panteleon, A.E., and Rebrin, K. (2004a). Closedloop insulin delivery - the path to physiological glucose control. Adv Drug Deliv Rev, 56(2), 125-144. doi: 10.1016/j.addr.2003.08.011. (Pubitemid 38114927)
32. Steil, G., Rebrin, K., and Mastrototaro, J.J. (2006a). Metabolic modelling and the closed-loop insulin delivery problem. Diabetes Res Clin Pract, 74 Suppl 2, S183-S186. doi: 10.1016/S0168-8227(06)70028-6. (Pubitemid 44917763)
33. Steil, G.M., Hwu, C., Janowski, R., Hariri, F., Jinagouda, S., Darwin, C., Tadros, S., Rebrin, K., and Saad, M.F. (2004b). Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. Diabetes, 53(5), 1201-1207. (Pubitemid 38569004)
34. Steil, G.M., Rebrin, K., Darwin, C., Hariri, F., and Saad, M.F. (2006b). Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes, 55(12), 3344-3350. doi:10.2337/db06-0419. (Pubitemid 44923591)
35. Steil, G.M., Rebrin, K., Janowski, R., Darwin, C., and Saad, M.F. (2003). Modeling β-cell insulin secretion - implications for closed-loop glucose homeostasis. Diabetes Technol Ther, 5(6), 953-964. doi:10.1089/ 152091503322640999. (Pubitemid 38009933)
36. Steil, G.M. and Rebrin, K. (2005). Closed-loop insulin delivery - what lies between where we are and where we are going? Expert Opin Drug Deliv, 2(2), 353-362. doi: 10.1517/17425247.2.2.353. (Pubitemid 41130888)
37. Steil, G.M. and Saad, M.F. (2006). Automated insulin delivery for type 1 diabetes. Curr Opin Endocrinol Diabetes, 13(2), 205-211.
38. Steil, G., Clark, B., Kanderian, S., and Rebrin, K. (2005). Modeling insulin action for development of a closed-loop artificial pancreas. Diabetes Technol Ther, 7(1), 94-108. doi: 10.1089/dia.2005.7.94. (Pubitemid 40354579)
39. Vuyk, J., Engbers, F.H.M., and Burm, A.G.L. (1995). Performance of computer-controlled infusion of propofol: An evaluation of five pharmacokinetic parameter sets. Anesth Analg, 81, 1275-1282.
40. Ward, W.K., Engle, J., Duman, H.M., Bergstrom, C.P., Kim, S.F., and Federiuk, I.F. (2008). The benefit of subcutaneous glucagon during closed-loop glycemic control in rats with type 1 diabetes. IEEE Sensors J, 8(1), 89-96. doi: 10.1109/JSEN.2007.912912.
41. Weinzimer, S.A., Steil, G.M., Swan, K.L., Dziura, J., Kurtz, N., and Tamborlane, W.V. (2008). Fully automated closedloop insulin delivery vs. semi-automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care, 31(5), 934-939. doi:10.2337/dc07-1967.